<i>PIK3CA</i> and <i>PIK3CB</i> Inhibition Produce Synthetic Lethality when Combined with Estrogen Deprivation in Estrogen Receptor–Positive Breast Cancer
Robert J. Crowder(University of Rochester), Matthew J. Ellis(Guardant (United States)), Jeremy Hoog(Washington University in St. Louis), Anthony J. Saporita, Jingqin Luo(Washington University in St. Louis), Joel S. Parker(University of North Carolina at Chapel Hill), Chanpheng Phommaly(Washington University in St. Louis), Charles M. Perou(University of North Carolina at Chapel Hill), Sherri R. Davies(Washington University in St. Louis), David G. Huntsman(BC Cancer Agency), Lin Li(Shanghai Jiao Tong University), Tao Yu(Weifang Medical University), Melinda A. Miller(University of North Carolina at Chapel Hill), Jacqueline Snider(Washington University in St. Louis), Jason D. Weber(Washington University in St. Louis), John A. Olson(Vanderbilt University), Mark A. Watson(Washington University in St. Louis)
Cited by 228
Related Papers
Integrated genomic analyses of ovarian carcinoma
|Nature|2011|8.2k
The Immune Landscape of Cancer
|Immunity|2018|6.3k
The Somatic Genomic Landscape of Glioblastoma
|Cell|2013|5.2k
Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
|The Lancet|2014|4.7k
Immunohistochemical and Clinical Characterization of the Basal-Like Subtype of Invasive Breast Carcinoma
|Clinical Cancer Research|2004|2.7k